March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Novel Immunophenotypic Profiles for Distinguishing Orbital MALT Lymphoma From Benign Orbital Lymphoproliferative Disorders
Author Affiliations & Notes
  • Shunichiro Ueda
    Tokyo Medical Univercity, Tokyo, Japan
  • Yoshihiko Usui
    Tokyo Medical Univercity, Tokyo, Japan
  • Taku Miyake
    Tokyo Medical Univercity, Tokyo, Japan
  • Keisuke Kimura
    Tokyo Medical Univercity, Tokyo, Japan
  • Hiroshi Goto
    Tokyo Medical Univercity, Tokyo, Japan
  • Footnotes
    Commercial Relationships  Shunichiro Ueda, None; Yoshihiko Usui, None; Taku Miyake, None; Keisuke Kimura, None; Hiroshi Goto, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5469. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shunichiro Ueda, Yoshihiko Usui, Taku Miyake, Keisuke Kimura, Hiroshi Goto; Novel Immunophenotypic Profiles for Distinguishing Orbital MALT Lymphoma From Benign Orbital Lymphoproliferative Disorders. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5469. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : It is important to distinguish orbital mucosa-associated lymphoid tissue (MALT) lymphoma and benign lymphoproliferative disorders such as IgG4-related lymphoproliferative disease (IgG4) and reactive lymphoid hyperplasia (RLH), since work-up as well as therapeutic strategy can vary greatly. In this study, we evaluate the immunophenotypic profiles of patients with orbital lymphoproliferative disorders as an aid in distinguishing orbital MALT lymphoma from benign disorders such as IgG4 or RLH.

Methods: : Biopsies proven 32 consecutive patients with newly diagnosed as orbital MALT lymphoma (n=17), RLH (n=10), and IgG4 (n=5) at Tokyo Medical University Hospital from 2006 to 2011 were recruited in this study. All cases of orbital MALT lymphoma patients showed Ig gene rearrangement. For flow cytometry analysis, cells were stained using fluorochrome-conjugated antibodies against mAb to CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD25, CD30, CD34, CD56 and polyclonal antibodies directed against Κ and .

Results: : Expression of CD25 was higher in patients with orbital MALT lymphoma compared to IgG4 or RLH (p<0.001). CD23 which is a low-affinity Fc receptor for IgE, is significantly expressed in orbital IgG4 or RLH compared to MALT lymphoma (p<0.001). T cell surface antigens such as CD2, CD3, CD4 were significantly expressed in orbital IgG4 or RLH compared to MALT lymphoma (p<0.001). Of MALT lymphoma, 9 cases showed Κ light-chain and 8 Κ light-chain reconstruction.

Conclusions: : These results suggest that the applicability of CD23 and CD25 analysis by flow cytometry as useful markers in distinguishing orbital MALT lymphoma from benign lymphoproliferative disorders such as IgG4 or RLH.

Keywords: tumors • flow cytometry • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×